EPISODE · May 7, 2026 · 39 MIN
From Omega-3s to Green-Lipped Mussel: What Matters in Joint Supplements for Dogs
from VetFolio Voice · host Powered by the NAVC
The joint supplement market has exploded, leaving veterinarians and pet owners alike awash in a sea of “hype.” While omega-3 fatty acids and green-lipped mussels have emerged as frontrunners in evidence-based products that support joint health, clinicians must be able to evaluate evidence, determine product quality, and understand the pharmacology behind the ingredients. Tune in to this episode of the VetFolio Voice podcast to provide the best care for your patients, gain a clinical and evidence-based toolkit for navigating the confusing market of canine joint supplements, and provide recommendations pet owners can trust. Be sure to log into VetFolio and take the quiz to qualify for your CE credit!https://www.vetfolio.com/courses/from-omega-3s-to-green-lipped-mussel-what-matters-in-joint-supplements-for-dogs
What this episode covers
The joint supplement market has exploded, leaving veterinarians and pet owners alike awash in a sea of “hype.” While omega-3 fatty acids and green-lipped mussels have emerged as frontrunners in evidence-based products that support joint health, clinicians must be able to evaluate evidence, determine product quality, and understand the pharmacology behind the ingredients. Tune in to this episode of the VetFolio Voice podcast to provide the best care for your patients, gain a clinical and evidence-based toolkit for navigating the confusing market of canine joint supplements, and provide recommendations pet owners can trust. Be sure to log into VetFolio and take the quiz to qualify for your CE credit!https://www.vetfolio.com/courses/from-omega-3s-to-green-lipped-mussel-what-matters-in-joint-supplements-for-dogs
NOW PLAYING
From Omega-3s to Green-Lipped Mussel: What Matters in Joint Supplements for Dogs
No transcript for this episode yet
Similar Episodes
Feb 17, 2026 ·56m
Feb 10, 2026 ·50m
Feb 3, 2026 ·47m
Jan 27, 2026 ·51m
Jan 20, 2026 ·54m